Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1999053925) PHYTOSTEROL FORMULATIONS TO LOWER CHOLESTEROL ABSORPTION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1999/053925 International Application No.: PCT/US1999/008413
Publication Date: 28.10.1999 International Filing Date: 16.04.1999
Chapter 2 Demand Filed: 08.11.1999
IPC:
A61K 45/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants:
STOHLER, Eric [US/US]; US (UsOnly)
MEDICAL ISOTOPES INC. [US/US]; 9 Valleyview Road Pelham, NH 03076, US (AllExceptUS)
Inventors:
STOHLER, Eric; US
Priority Data:
60/082,11417.04.1998US
Title (EN) PHYTOSTEROL FORMULATIONS TO LOWER CHOLESTEROL ABSORPTION
(FR) FORMULATIONS DE PHYTOSTEROL PERMETTANT DE DIMINUER L'ABSORPTION DE CHOLESTEROL
Abstract:
(EN) A composition for reducing cholesterol absorption from the intestine comprised of sitostanol (or other phytosterols) and lecithin (or other phospholipids) in proportions of 1:1 to 1:50 of sitostanol (or other phytosterols and lecithin or other phospholipids).
(FR) L'invention concerne une composition qui permet de réduire l'absorption de cholestérol depuis l'intestin, constituée de sitostanol (ou autres phytostérols) et de lécithine (ou autres phospholipides) dans les proportions suivante: de 1:1 à 1:50 pour le sitostanol (ou autres phytostérols) et pour la lécithine (ou autres phospholipides).
Designated States: AU, CA, JP, US
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)